The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerinus Energy Regulatory News (SENX)

Share Price Information for Serinus Energy (SENX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.90
Bid: 2.80
Ask: 3.00
Change: 0.00 (0.00%)
Spread: 0.20 (7.143%)
Open: 2.90
High: 2.90
Low: 2.90
Prev. Close: 2.90
SENX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Management Incentivisation Scheme

21 Dec 2020 08:45

RNS Number : 3418J
Serinus Energy PLC
21 December 2020
 

21 December 2020

 

Press Release

Management Incentivisation Scheme

Jersey, Channel Islands, 21 December 2020 -- Serinus Energy plc ("Serinus", or the "Company") (AIM:SENX, WSE:SEN) announces that the Board of Directors has approved an incentivisation programme for the staff and management of Serinus.

Whilst management has delivered significant operational successes in recent years in both Tunisia and Romania, the disruptions of the global COVID-19 pandemic impacted the ability of the Company to generate sufficient operating cash flow to service the Company's debt. Serinus subsequently negotiated the recapitalisation of the business by retiring all of its outstanding debt with the European Bank for Reconstruction and Development ("EBRD"). As a result, current arrangements no longer represent a deliverable incentive for staff and management whose loyalty and embedded knowledge are crucial to the next stage of development of the Company.

Accordingly, the Board has decided that 14,293,000 share options already awarded to management and staff under the Company's Share Option Scheme will be rebased to 2p to match the price at which equity was raised for the recapitalisation of the business. A further issue of 18,800,000 options at the same price will be granted to Jeffrey Auld, CEO, these options vest over multiple years with the first tranche of one third of the options vesting immediately, a further third of the options vest in one year, and a final third in two years.

The Board has also approved a grant of 22,500,000 shares issued at nil cost under the Company's existing Long Term Incentive Plan Scheme for six members of the management team including directors, Jeffrey Auld (13,000,000 shares) and Andrew Fairclough (7,000,000 Shares), who have been closely involved with the recapitalisation of the Company in recognition of the success and magnitude of this project. Application has been made to the London Stock Exchange for these 22,500,000 Shares to be admitted to trading on AIM. Admission is expected on 24 December 2020.

The Awards have been made under the existing Long Term Incentive Plan, as approved by the board on 1 October 2018. The total number of options and shares issued or repriced under the revised awards as disclosed in this announcement is 55,593,000 or 4.87% of the issued and outstanding shares following the recapitalisation.

Related party transaction

Under the Aim Rules for Companies, these arrangements with the directors form a Related Party Transaction. Accordingly, the Independent Directors, being the directors other than Jeffrey Auld and Andrew Fairclough, consider, having consulted with Arden Partners, the Company's Nominated Adviser, that the terms of the Awards are fair and reasonable insofar as shareholders are concerned.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Jeffrey Auld

2

Reason for the notification

a)

Position/status

Chief Executive

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Serinus Energy plc

b)

LEI

549300W183KUX62DVI32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Award of shares and Options over Ordinary shares of Serinus Energy plc

 

 

Identification code (ISIN) for Serinus Energy PLC ordinary shares: JE00BF4N9R98

b)

Nature of the transaction

Grant of Options, Repricing of existing options, Award of shares under LTIP

c)

Price(s) and volume(s)

Price(s)

Volume(s)

2p

18,800,000

New Options

2p

8,000,000

Repriced options

nil

13,000,000

Award under LTIP

 

d)

Aggregated information

- Aggregated volume

- Price

See above

e)

Date of the transaction

21 December 2020

f)

Place of the transaction

London Stock Exchange, (XLON)

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andrew Fairclough

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Serinus Energy plc

b)

LEI

549300W183KUX62DVI32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Award of shares and Options over Ordinary shares of Serinus Energy plc

 

 

Identification code (ISIN) for Serinus Energy plc ordinary shares: JE00BF4N9R98

b)

Nature of the transaction

Repricing of existing options, Award of shares under LTIP

c)

Price(s) and volume(s)

Price(s)

Volume(s)

2p

1,750,000

Repriced options

nil

7,000,000

Award under LTIP

 

d)

Aggregated information

- Aggregated volume

- Price

See above

e)

Date of the transaction

21 December 2020

f)

Place of the transaction

London Stock Exchange, (XLON)

 

About Serinus

Serinus is an international upstream oil and gas exploration and production company that owns and operates projects in Tunisia and Romania.

For further information, please refer to the Serinus website (www.serinusenergy.com) or contact the following:

Serinus Energy plc

Jeffrey Auld, Chief Executive Officer

Andrew Fairclough, Chief Financial Officer

Calvin Brackman, Vice President, External Relations & Strategy

+44 208 054 2859

Arden Partners plc

(Nominated Adviser & Joint Broker)

Paul Shackleton / Dan Gee-Summons (Corporate Finance)

Tim Dainton (Equity Sales)

+44 207 614 5900

Shore Capital Stockbrokers Limited (Joint Broker)

Toby Gibbs / John More (Corporate Advisory)

Jerry Keen (Corporate Broking)

+44 207 408 4090

Camarco

(Financial PR - London)Billy CleggOwen Roberts

+44 203 781 8334

TBT i Wspólnicy

(Financial PR - Warsaw)

Katarzyna Terej

+48 602 214 353

 

Translation: This news release has been translated into Polish from the English original.

Forward-looking Statements This release may contain forward-looking statements made as of the date of this announcement with respect to future activities that either are not or may not be historical facts. Although the Company believes that its expectations reflected in the forward-looking statements are reasonable as of the date hereof, any potential results suggested by such statements involve risk and uncertainties and no assurance can be given that actual results will be consistent with these forward-looking statements. Various factors that could impair or prevent the Company from completing the expected activities on its projects include that the Company's projects experience technical and mechanical problems, there are changes in product prices, failure to obtain regulatory approvals, the state of the national or international monetary, oil and gas, financial , political and economic markets in the jurisdictions where the Company operates and other risks not anticipated by the Company or disclosed in the Company's published material. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties and actual results may vary materially from those expressed in the forward-looking statement. The Company undertakes no obligation to revise or update any forward-looking statements in this announcement to reflect events or circumstances after the date of this announcement, unless required by law.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKKDBBFBDKKBB
Date   Source Headline
7th May 20247:00 amRNSQ1 2024 Results Investor Presentation
18th Apr 20247:00 amRNSNotice of Annual General Meeting
11th Mar 20247:00 amRNS2023 Annual Results Investor Presentation
20th Feb 20246:31 pmRNSHolding(s) in Company
26th Jan 20247:00 amRNSHolding(s) in Company
23rd Jan 20247:00 amRNSParticipation in Onshore Angola Licence Round
3rd Jan 20247:00 amRNSHolding(s) in Company
27th Nov 20237:00 amRNSQ3 2023 Results
20th Nov 20237:00 amRNSInvestor Presentation
10th Nov 20237:00 amRNSHolding(s) in Company
6th Nov 20237:00 amRNSHolding(s) in Company
1st Nov 20237:00 amRNSHolding(s) in Company
31st Oct 20237:00 amRNSLicence Extension of Satu Mare Concession
23rd Oct 20237:00 amRNSHolding(s) in Company
22nd Sep 20237:00 amRNSDirector/PDMR Exercise of Options
4th Sep 20237:00 amRNSDirector/PDMR Shareholding
4th Sep 20237:00 amRNSAppointment of Chief Financial Officer
18th Aug 20234:12 pmRNSHolding(s) in Company
18th Aug 20237:00 amRNSDirector/PDMR Purchase of Shares
18th Aug 20237:00 amRNSHolding(s) in Company
18th Aug 20237:00 amRNSDirector/PDMR Purchase of Shares
17th Aug 20235:32 pmRNSReplacement - Holding(s) in Company
17th Aug 20237:00 amRNSHolding(s) in Company
17th Aug 20237:00 amRNSHolding(s) in Company
17th Aug 20237:00 amRNSHolding(s) in Company
16th Aug 20237:00 amRNSDirector/PDMR Purchase of Shares
14th Aug 20237:00 amRNSInterim Results for Six Months Ended 30 June 2023
7th Aug 20237:00 amRNSInvestor Presentation
5th Jun 20237:00 amRNSCompletion of Sabria N-2 Well Workover in Tunisia
2nd Jun 20233:53 pmRNSAward under Long-Term Incentive Plan
11th May 202311:55 amRNSVoting Results from AGM
11th May 20237:00 amRNSInterim Results for 3 months ended 31 March 2023
10th May 20235:22 pmRNSDirector Resignation
9th May 20237:00 amRNSArden Capital Joint Broker Agreement Terminated
4th May 20237:00 amRNSInvestor Presentation
2nd May 20237:00 amRNSN-2 Well Workover in Tunisia
18th Apr 20237:00 amRNSNotice of AGM
3rd Apr 20237:00 amRNSWell Workover Programme in Tunisia
20th Mar 20237:00 amRNSAnnual Financial Results for 2022
13th Mar 20237:00 amRNSInvestor Presentation
15th Feb 20237:00 amRNSSerinus Wins Arbitration Case
6th Jan 20237:00 amRNSTransaction in Own Shares
15th Dec 20227:00 amRNSW-1 Well Workover in Tunisia
28th Nov 20227:00 amRNSQ3 2022 Results
21st Nov 20227:00 amRNSInvestor Presentation
28th Oct 20227:00 amRNSTransaction in Own Shares
27th Oct 20227:00 amRNSTransaction in Own Shares
26th Oct 20227:00 amRNSTransaction in Own Shares
13th Oct 20227:00 amRNSHolding(s) in Company
12th Oct 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.